Skip to main content

Table 9 Prevalent dialysis patient distribution by age and primary disease

From: Annual Dialysis Data Report 2014, JSDT Renal Data Registry (JRDR)

Primary disease <5 5~9 10~14 15~19 20~24 25~29 30~34 35~39 40~44 45~49 50~54 55~59 60~64 65~69 70~74 75~79 80~84 85~89 90~94 95 Subtotal Unspecified No information on birth date Total Mean age S.D.
Chronic glomerulonephritis 1 4 6 28 71 242 647 1490 3009 4586 5996 8561 13,680 16,778 15,287 12,066 8773 4446 1139 160 96,970    96,970 66.54 12.47
(%) (2.4) (12.5) (13.6) (25.7) (28.9) (35.5) (36.7) (37.0) (35.0) (34.5) (33.5) (33.8) (33.9) (32.1) (31.0) (28.6) (27.3) (26.7) (26.0) (25.9) (31.3)    (31.3)   
Chronic pyelonephritis     1 6 19 35 90 133 170 191 251 353 494 466 372 261 150 42 7 3041 1   3042 65.46 13.88
(%)     (0.9) (2.4) (2.8) (2.0) (2.2) (1.5) (1.3) (1.1) (1.0) (0.9) (0.9) (0.9) (0.9) (0.8) (0.9) (1.0) (1.1) (1.0) (4.8)   (1.0)   
RPGN   2    5 12 18 36 67 91 103 151 277 381 438 391 317 165 35 5 2494    2494 68.92 12.99
(%)   (6.3)    (2.0) (1.8) (1.0) (0.9) (0.8) (0.7) (0.6) (0.6) (0.7) (0.7) (0.9) (0.9) (1.0) (1.0) (0.8) (0.8) (0.8)    (0.8)   
PIH        7 11 50 83 124 163 305 342 270 166 71 20 2   1614    1614 64.49 10.24
(%)        (0.4) (0.3) (0.6) (0.6) (0.7) (0.6) (0.8) (0.7) (0.5) (0.4) (0.2) (0.1) (0.0)   (0.5)    (0.5)   
Unclassified nephritis 1 2 6 6 21 29 42 69 94 109 106 113 142 143 185 136 96 51 19 3 1373    1373 60.35 17.10
(%) (2.4) (6.3) (13.6) (5.5) (8.5) (4.3) (2.4) (1.7) (1.1) (0.8) (0.6) (0.4) (0.4) (0.3) (0.4) (0.3) (0.3) (0.3) (0.4) (0.5) (0.4)    (0.4)   
PKD 5 2   3 6 12 30 94 288 576 930 1274 1891 1980 1640 1177 727 299 62 10 11,006    11,006 65.01 11.29
(%) (12.2) (6.3)   (2.8) (2.4) (1.8) (1.7) (2.3) (3.4) (4.3) (5.2) (5.0) (4.7) (3.8) (3.3) (2.8) (2.3) (1.8) (1.4) (1.6) (3.5)    (3.5)   
Nephrosclerosis    2 2 12 29 60 144 389 611 745 1209 2092 3258 4221 5003 5469 3625 1244 182 28,297 1   28,298 73.99 11.76
(%)    (4.5) (1.8) (4.9) (4.3) (3.4) (3.6) (4.5) (4.6) (4.2) (4.8) (5.2) (6.2) (8.6) (11.8) (17.0) (21.8) (28.4) (29.4) (9.1) (4.8)   (9.1)   
Hypertensive emergencies      3 9 44 94 150 188 217 220 294 332 305 272 250 143 43 9 2573    2573 64.20 14.83
(%)      (1.2) (1.3) (2.5) (2.3) (1.7) (1.4) (1.2) (0.9) (0.7) (0.6) (0.6) (0.6) (0.8) (0.9) (1.0) (1.5) (0.8)    (0.8)   
Diabetes 2 1 2 8 7 35 313 1048 2859 4831 7042 10,197 16,451 22,304 20,127 16,494 10,789 4570 901 98 118,079 2   118,081 67.33 11.28
(%) (4.9) (3.1) (4.5) (7.3) (2.8) (5.1) (17.7) (26.0) (33.3) (36.3) (39.3) (40.2) (40.8) (42.7) (40.8) (39.0) (33.6) (27.4) (20.5) (15.9) (38.1) (9.5)   (38.1)   
Lupus    1 5 9 24 41 80 138 207 214 261 298 324 244 202 116 61 10 1 2236    2236 60.73 13.97
(%)    (2.3) (4.6) (3.7) (3.5) (2.3) (2.0) (1.6) (1.6) (1.2) (1.0) (0.7) (0.6) (0.5) (0.5) (0.4) (0.4) (0.2) (0.2) (0.7)    (0.7)   
Amyloidosis         4 19 19 27 27 56 77 86 70 47 15 4   451    451 67.50 11.65
(%)         (0.1) (0.2) (0.1) (0.2) (0.1) (0.1) (0.1) (0.2) (0.2) (0.1) (0.1) (0.1)   (0.1)    (0.1)   
Gout       1 3 8 29 40 68 82 152 201 207 181 96 39 4 1 1112 1   1113 67.56 11.06
(%)       (0.1) (0.2) (0.2) (0.3) (0.3) (0.4) (0.3) (0.4) (0.4) (0.4) (0.4) (0.3) (0.2) (0.1) (0.2) (0.4) (4.8)   (0.4)   
Inborn errors of metabolism 2    5 10 17 19 29 39 30 17 23 27 23 13 7 4 7    272    272 48.99 16.94
(%) (4.9)    (4.6) (4.1) (2.5) (1.1) (0.7) (0.5) (0.2) (0.1) (0.1) (0.1) (0.0) (0.0) (0.0) (0.0) (0.0)    (0.1)    (0.1)   
Tuberculosis           1 4 9 19 47 54 20 37 10 5   206    206 72.33 8.75
(%)           (0.0) (0.0) (0.0) (0.0) (0.1) (0.1) (0.0) (0.1) (0.1) (0.1)   (0.1)    (0.1)   
Urolithiasis        1 3 8 11 26 44 60 97 103 94 85 38 10 1 581    581 70.48 11.08
(%)        (0.1) (0.1) (0.1) (0.1) (0.1) (0.2) (0.1) (0.2) (0.2) (0.2) (0.3) (0.2) (0.2) (0.2) (0.2)    (0.2)   
Neoplasm of kidney and urinary tract     1   1 3 7 7 11 19 39 76 139 173 154 174 62 17 3 886    886 72.53 10.68
(%)     (0.9)   (0.1) (0.2) (0.2) (0.1) (0.1) (0.1) (0.2) (0.2) (0.3) (0.4) (0.4) (0.5) (0.4) (0.4) (0.5) (0.3)    (0.3)   
Urinary tract obstructive 1   1   3 9 27 42 41 43 42 32 66 90 102 89 88 36 10   722 1   723 63.81 16.72
(%) (2.4)   (2.3)   (1.2) (1.3) (1.5) (1.0) (0.5) (0.3) (0.2) (0.1) (0.2) (0.2) (0.2) (0.2) (0.3) (0.2) (0.2)   (0.2) (4.8)   (0.2)   
Myeloma     2    1 1 6 6 10 12 29 51 50 43 38 22 2 3 276    276 70.55 12.17
(%)     (1.8)    (0.1) (0.0) (0.1) (0.0) (0.1) (0.0) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.0) (0.5) (0.1)    (0.1)   
Hypoplastic kidney 10 11 13 21 29 47 71 94 72 67 38 29 30 34 32 26 15 6 4   649    649 44.24 19.08
(%) (24.4) (34.4) (29.5) (19.3) (11.8) (6.9) (4.0) (2.3) (0.8) (0.5) (0.2) (0.1) (0.1) (0.1) (0.1) (0.1) (0.0) (0.0) (0.1)   (0.2)    (0.2)   
Undetermined 2   2 11 23 69 185 382 712 992 1236 1757 2937 3907 4152 4201 3732 2418 698 114 27,530 14   27,544 69.80 13.13
(%) (4.9)   (4.5) (10.1) (9.3) (10.1) (10.5) (9.5) (8.3) (7.5) (6.9) (6.9) (7.3) (7.5) (8.4) (9.9) (11.6) (14.5) (15.9) (18.4) (8.9) (66.7)   (8.9)   
Rejected kidney    2 1 12 22 64 91 181 240 315 367 332 257 115 73 58 22 10 1 2163    2163 56.37 12.59
(%)    (4.5) (0.9) (4.9) (3.2) (3.6) (2.3) (2.1) (1.8) (1.8) (1.4) (0.8) (0.5) (0.2) (0.2) (0.2) (0.1) (0.2) (0.2) (0.7)    (0.7)   
Others 17 10 9 15 29 105 153 208 305 393 443 529 785 1000 1097 1014 844 454 126 20 7556 1   7557 65.60 15.70
(%) (41.5) (31.3) (20.5) (13.8) (11.8) (15.4) (8.7) (5.2) (3.5) (3.0) (2.5) (2.1) (1.9) (1.9) (2.2) (2.4) (2.6) (2.7) (2.9) (3.2) (2.4) (4.8)   (2.4)   
Subtotal 41 32 44 109 246 682 1764 4025 8596 13,305 17,913 25,350 40,352 52,259 49,367 42,251 32,087 16,659 4387 618 310,087 21   310,108 67.54 12.49
(%) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0)   (100.0)   
No information available
(%)                           
Total 41 32 44 109 246 682 1764 4025 8596 13,305 17,913 25,350 40,352 52,259 49,367 42,251 32,087 16,659 4387 618 310,087 21   310,108 67.54 12.49
(%)                           
  1. Values in parentheses under each figure represent the percentage relative to the subtotal in each row
  2. The column “No information on birth date” shows the number of patients who provided no date of birth; thus, the calculation of age was impossible
  3. RPGN Rapidly progressive glomerulonephritis, PIH Pregnancy-induced hypertension, PKD polycystic kidney disease